USD
$0.00
(0.00%
)At Close (As of Dec 16, 2025)
$622.11M
Market Cap
-
P/E Ratio
-3.03
EPS
$20.48
52 Week High
$10.24
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $546M |
| Total Revenue | $799M |
| Cost Of Revenue | $254M |
| Costof Goods And Services Sold | $254M |
| Operating Income | -$85M |
| Selling General And Administrative | $533M |
| Research And Development | $74M |
| Operating Expenses | $631M |
| Investment Income Net | - |
| Net Interest Income | -$30M |
| Interest Income | - |
| Interest Expense | $30M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $60M |
| Income Before Tax | -$124M |
| Income Tax Expense | $2.1M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$126M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$94M |
| Ebitda | -$34M |
| Net Income | -$126M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $546M |
| Total Revenue | $799M |
| Cost Of Revenue | $254M |
| Costof Goods And Services Sold | $254M |
| Operating Income | -$85M |
| Selling General And Administrative | $533M |
| Research And Development | $74M |
| Operating Expenses | $631M |
| Investment Income Net | - |
| Net Interest Income | -$30M |
| Interest Income | - |
| Interest Expense | $30M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $60M |
| Income Before Tax | -$124M |
| Income Tax Expense | $2.1M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$126M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$94M |
| Ebitda | -$34M |
| Net Income | -$126M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Orthofix Medical Inc. (OFIX) is a leading global medical device company based in Lewisville, Texas, focused on delivering innovative surgical and non-surgical solutions for spine and orthopedic applications. With established operations in significant markets including the United States, Italy, Germany, the United Kingdom, and Brazil, Orthofix is committed to improving patient outcomes through advanced technologies and biopharmaceutical products. The company’s extensive research and development efforts underpin its competitive advantage, positioning Orthofix to effectively respond to the evolving demands of healthcare practitioners and enhance its growth trajectory in the dynamic medical device industry.